Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Heart Failure: A Systematic Review of Randomized Controlled Trials and Real-World Evidence.

Ibrahim MO, Mohamed OM, Ali NM

Open source

DOI
10.7759/cureus.90684
Published
2025 Aug
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.90684,
  title = {Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Heart Failure: A Systematic Review of Randomized Controlled Trials and Real-World Evidence.},
  author = {Ibrahim MO and Mohamed OM and Ali NM},
  year = {2025},
  journal = {Cureus},
  doi = {10.7759/cureus.90684},
  url = {https://doi.org/10.7759/cureus.90684}
}

RIS

TY  - JOUR
TI  - Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Heart Failure: A Systematic Review of Randomized Controlled Trials and Real-World Evidence.
AU  - Ibrahim MO
AU  - Mohamed OM
AU  - Ali NM
PY  - 2025
JO  - Cureus
DO  - 10.7759/cureus.90684
UR  - https://doi.org/10.7759/cureus.90684
ER  - 

APA

MO, I., OM, M., & NM, A. (2025). Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Heart Failure: A Systematic Review of Randomized Controlled Trials and Real-World Evidence.. Cureus. https://doi.org/10.7759/cureus.90684

Source records